Yuan‐Pin Hung

1.8k total citations
75 papers, 1.2k citations indexed

About

Yuan‐Pin Hung is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Yuan‐Pin Hung has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 46 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Yuan‐Pin Hung's work include Clostridium difficile and Clostridium perfringens research (43 papers), Microscopic Colitis (32 papers) and Helicobacter pylori-related gastroenterology studies (15 papers). Yuan‐Pin Hung is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (43 papers), Microscopic Colitis (32 papers) and Helicobacter pylori-related gastroenterology studies (15 papers). Yuan‐Pin Hung collaborates with scholars based in Taiwan, United States and Chile. Yuan‐Pin Hung's co-authors include Wen‐Chien Ko, Jen‐Chieh Lee, Pei-Jane Tsai, Ching‐Chi Lee, Hsiao-Ju Lin, Pei-Jane Tsai, Yi‐Hui Wu, Po‐Lin Chen, I‐Hsiu Huang and Nan–Yao Lee and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Yuan‐Pin Hung

68 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan‐Pin Hung Taiwan 20 748 536 226 166 150 75 1.2k
G Ackermann Germany 21 744 1.0× 477 0.9× 174 0.8× 92 0.6× 160 1.1× 39 1.1k
Jerina Boelens Belgium 20 487 0.7× 734 1.4× 279 1.2× 85 0.5× 139 0.9× 83 1.8k
Elena Reigadas Spain 19 1.1k 1.5× 771 1.4× 224 1.0× 216 1.3× 176 1.2× 63 1.3k
Nicole J. Pultz United States 20 753 1.0× 193 0.4× 432 1.9× 108 0.7× 79 0.5× 24 1.3k
Hanna Pituch Poland 22 1.4k 1.9× 798 1.5× 371 1.6× 243 1.5× 282 1.9× 83 1.7k
Marco Cassone United States 23 494 0.7× 571 1.1× 583 2.6× 69 0.4× 104 0.7× 72 1.9k
Farzin Khorvash Iran 18 340 0.5× 266 0.5× 187 0.8× 83 0.5× 102 0.7× 109 1.1k
Cornelis W. Knetsch Netherlands 16 856 1.1× 489 0.9× 439 1.9× 86 0.5× 188 1.3× 26 1.3k
Carol J. Shanholtzer United States 17 815 1.1× 694 1.3× 126 0.6× 199 1.2× 164 1.1× 32 1.4k
Grace C. Lee United States 17 339 0.5× 328 0.6× 205 0.9× 88 0.5× 69 0.5× 41 1.1k

Countries citing papers authored by Yuan‐Pin Hung

Since Specialization
Citations

This map shows the geographic impact of Yuan‐Pin Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Pin Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Pin Hung more than expected).

Fields of papers citing papers by Yuan‐Pin Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Pin Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Pin Hung. The network helps show where Yuan‐Pin Hung may publish in the future.

Co-authorship network of co-authors of Yuan‐Pin Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Pin Hung. A scholar is included among the top collaborators of Yuan‐Pin Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Pin Hung. Yuan‐Pin Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, I‐Hsiu, et al.. (2025). Combination of mitomycin C and low-dose metronidazole synergistically against Clostridioides difficile infection and recurrence prevention. Antimicrobial Agents and Chemotherapy. 69(8). e0051525–e0051525.
4.
Hung, Yuan‐Pin, et al.. (2022). A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox. Journal of Microbiology Immunology and Infection. 55(5). 795–802. 10 indexed citations
5.
Hsu, Chih‐Yu, et al.. (2022). Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice. Antibiotics. 11(1). 116–116. 1 indexed citations
6.
Lee, Ching‐Chi, et al.. (2022). Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections. Infection and Drug Resistance. Volume 15. 5387–5396.
8.
Hung, Yuan‐Pin, Chin-Shiang Tsai, Pei-Jane Tsai, et al.. (2021). Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. Journal of Microbiology Immunology and Infection. 54(6). 1101–1110. 12 indexed citations
10.
Tsai, Pei-Jane, et al.. (2021). Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability?. Journal of Microbiology Immunology and Infection. 54(6). 1011–1017. 12 indexed citations
11.
Hung, Yuan‐Pin, et al.. (2021). Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases. Pharmaceutics. 13(11). 1913–1913. 14 indexed citations
12.
Tang, Hung-Jen, Yi‐Shan Tsai, Nan–Yao Lee, et al.. (2021). Risk of non-typhoidal Salmonella vascular infections is increased with degree of atherosclerosis and inflammation: A multicenter study in southern Taiwan. Journal of Microbiology Immunology and Infection. 55(3). 474–481. 7 indexed citations
13.
Hung, Yuan‐Pin, Ching‐Chi Lee, Jen‐Chieh Lee, Pei-Jane Tsai, & Wen‐Chien Ko. (2021). Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics. Microorganisms. 9(8). 1605–1605. 32 indexed citations
14.
Hung, Yuan‐Pin, Jen‐Chieh Lee, Jia-Ling Wu, et al.. (2019). Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration. Journal of Microbiology Immunology and Infection. 54(2). 276–283. 32 indexed citations
15.
Wang, Jiun‐Ling, Ching‐Chi Lee, Chung-Hsun Lee, et al.. (2018). Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia. Journal of Clinical Medicine. 7(12). 508–508. 7 indexed citations
16.
Tsai, Chin-Shiang, Yuan‐Pin Hung, Nan–Yao Lee, et al.. (2016). Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007–2015. Journal of Microbiology Immunology and Infection. 51(2). 243–250. 11 indexed citations
17.
Hung, Yuan‐Pin, Jen‐Chieh Lee, Hsiao-Ju Lin, et al.. (2015). Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection. Antibiotics. 4(2). 216–229. 15 indexed citations
18.
Hung, Yuan‐Pin, Hsiao-Ju Lin, Jen‐Chieh Lee, et al.. (2015). Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents. Journal of Microbiology Immunology and Infection. 49(4). 584–590. 12 indexed citations
19.
Hung, Yuan‐Pin, Hsiao-Ju Lin, Jen‐Chieh Lee, et al.. (2014). Clostridium difficile ribotype 126 in southern Taiwan: A cluster of three symptomatic cases. Anaerobe. 30. 188–192. 25 indexed citations
20.
Hung, Yuan‐Pin, Hsiao-Ju Lin, Chi-Jung Wu, et al.. (2014). Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection. Anaerobe. 30. 24–26. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026